KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Equity Ratio (2016 - 2025)

Pfizer (PFE) has disclosed Equity Ratio for 17 consecutive years, with 0.42 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 0.52% to 0.42 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42 through Dec 2025, up 0.52% year-over-year, with the annual reading at 0.42 for FY2025, 0.52% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.42 at Pfizer, down from 0.45 in the prior quarter.
  • The five-year high for Equity Ratio was 2.26 in Q4 2022, with the low at 0.39 in Q4 2023.
  • Average Equity Ratio over 5 years is 0.54, with a median of 0.43 recorded in 2021.
  • The sharpest move saw Equity Ratio soared 193.04% in 2022, then plummeted 79.98% in 2023.
  • Over 5 years, Equity Ratio stood at 0.43 in 2021, then rose by 13.95% to 0.49 in 2022, then decreased by 18.95% to 0.39 in 2023, then grew by 5.2% to 0.41 in 2024, then increased by 0.52% to 0.42 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.42, 0.45, and 0.43 for Q4 2025, Q3 2025, and Q2 2025 respectively.